UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)     AUGUST 27, 2004
                                                   --------------------


                               HENRY SCHEIN, INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)



          DELAWARE                       0-27078                 11-3136595
--------------------------------------------------------------------------------
(State or other jurisdiction         (Commission File           IRS  Employer
     of incorporation)                    Number)           (Identification No.)


   135 DURYEA ROAD MELVILLE, NEW YORK                                   11747
--------------------------------------------------------------------------------
(Address of principal executive offices)                             (Zip Code)

Registrant's telephone number, including area code   (631) 843-5500
                                                    -----------------


                                 NOT APPLICABLE
--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))



Item 8.01.  Other Events.

            On August 27, 2004, Henry Schein, Inc. issued a press release
announcing that it expects to begin shipping Fluvirin(R) influenza vaccine
orders in early October, 2004 and reaffirming 2004 guidance.

Item 9.01.  Financial Statements and Exhibits.

            (a)  Not applicable.

            (b)  Not applicable.

            (c)  Exhibits.  99.1  Press Release, dated August 27, 2004.


                                    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                                HENRY SCHEIN, INC.


                                                By:  /s/ Michael S. Ettinger
                                                     ---------------------------
                                                Name: Michael S. Ettinger
                                                Title: Secretary, Vice President
                                                       and General Counsel


Date:  August 30, 2004




                                  EXHIBIT INDEX


Exhibit No.      Description

99.1             Press Release dated August 27, 2004.